The glucose lowering effect of small molecule GPR120 agonists is driven by glucagon-like peptide

被引：0
|
作者：
Winzell, M. S. [1 ]
Myhre, S. [1 ]
Sundstrom, L. [1 ]
Ahnmark, A. [1 ]
Nystrom, A. -C. [1 ]
Sundqvist, M. [1 ]
Nagard, M. [1 ]
机构：
[1] AstraZeneca R&D, Cardiovasc & Metab Dis, Molndal, Sweden
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
559
引用
收藏
页码：S272 / S272
页数：1
相关论文
共 50 条
  • [1] The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1
    Sundstrom, Linda
    Myhre, Susanna
    Sundqvist, Monika
    Ahnmark, Andrea
    McCoull, William
    Raubo, Piotr
    Groombridge, Sam D.
    Polla, Magnus
    Nystrom, Ann-Christin
    Kristensson, Lisbeth
    Nagard, Mats
    Winzell, Maria Sorhede
    [J]. PLOS ONE, 2017, 12 (12):
  • [2] Small-molecule agonists for the glucagon-like peptide 1 receptor
    Knudsen, Lotte Bjerre
    Kiel, Dan
    Teng, Min
    Behrens, Carsten
    Bhumralkar, Dilip
    Kodra, Janos T.
    Holst, Jens J.
    Jeppesen, Claus B.
    Johnson, Michael D.
    de Jong, Johannes Cornelis
    Jorgensen, Anker Steen
    Kercher, Tim
    Kostrowicki, Jarek
    Madsen, Peter
    Olesen, Preben H.
    Petersen, Jacob S.
    Poulsen, Fritz
    Sidelmann, Ulla G.
    Sturis, Jeppe
    Truesdale, Larry
    May, John
    Lau, Jesper
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (03) : 937 - 942
  • [3] Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
    Hirasawa, A
    Tsumaya, K
    Awaji, T
    Katsuma, S
    Adachi, T
    Yamada, M
    Sugimoto, Y
    Miyazaki, S
    Tsujimoto, G
    [J]. NATURE MEDICINE, 2005, 11 (01) : 90 - 94
  • [4] Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
    Akira Hirasawa
    Keiko Tsumaya
    Takeo Awaji
    Susumu Katsuma
    Tetsuya Adachi
    Masateru Yamada
    Yukihiko Sugimoto
    Shunichi Miyazaki
    Gozoh Tsujimoto
    [J]. Nature Medicine, 2005, 11 : 90 - 94
  • [5] Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
    Hirasawa, A
    Tsumaya, K
    Awaji, T
    Katsuma, S
    Adachi, T
    Yamada, M
    Sugimoto, Y
    Miyazaki, S
    Tsujimoto, G
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 125P - 125P
  • [6] Glucose Lowering Efficacy of Glucagon-Like Peptide-1 Receptor Agonists: A Meta-Analysis
    Vilsboll, Tina
    Christensen, Mikkel
    Knop, Filip K.
    Gluud, Lise L.
    [J]. DIABETES, 2011, 60 : A295 - A295
  • [7] Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin
    Bahne, Emilie
    Hansen, Morten
    Bronden, Andreas
    Sonne, David P.
    Vilsboll, Tina
    Knop, Filip K.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (10): : 955 - 961
  • [8] Fluorescent Ligand-Based Discovery of Small-Molecule Sulfonamide Agonists for GPR120
    Ma, Siyue
    Li, Zhenzhen
    Yang, Yueli
    Zhang, Ling
    Li, Minyong
    Du, Lupei
    [J]. FRONTIERS IN CHEMISTRY, 2022, 10
  • [9] Beyond glucose lowering: Glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system
    Verges, B.
    Bonnard, C.
    Renard, E.
    [J]. DIABETES & METABOLISM, 2011, 37 (06) : 477 - 488
  • [10] Cyclobutane Derivatives As Novel Nonpeptidic Small Molecule Agonists of Glucagon-Like Peptide-1 Receptor
    Liu, Qing
    Li, Na
    Yuan, Yunyun
    Lu, Huili
    Wu, Xiaoyan
    Zhou, Caihong
    He, Min
    Su, Haoran
    Zhang, Meng
    Wang, Jia
    Wang, Bao
    Wang, You
    Ma, Dawei
    Ye, Yang
    Weiss, Hans-Christoph
    Gesing, Ernst R. F.
    Liao, Jiayu
    Wang, Ming-Wei
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 250 - 267
12345